查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
急性胰臟炎市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品、原因、最終用戶和地理位置
市場調查報告書
商品編碼
1362424

急性胰臟炎市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品、原因、最終用戶和地理位置

Acute Pancreatitis Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Offerings, Causes, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 196 Pages | 訂單完成後即時交付

價格

急性胰臟炎市場規模預計將從2022年的56.4977億美元增至2030年的88.2737億美元；預計2022年至2030年年複合成長率為5.7%。

胰臟產生胰島素，一種調節血糖水準的荷爾蒙。胰臟炎會損害胰臟中產生胰島素的細胞，進而導致急性胰臟炎患者罹患糖尿病。患有急性胰臟炎的人患糖尿病的風險是一般人群的兩倍。世界衛生組織(WHO)美國糖尿病協會將急性胰臟炎後發生的糖尿病歸類為外分泌性胰臟糖尿病(胰源性糖尿病)。胰源性糖尿病越來越多與胰臟外分泌疾病有關。在急性胰臟炎的各種嚴重程度中都觀察到糖尿病後遺症，並且可能伴隨其他臨床併發症。

根據2022年發布的《歐洲醫學和藥理學科學評論》，西方糖尿病人群中胰源性糖尿病的盛行率為5-10%，其中慢性胰臟炎佔20%，急性胰臟炎佔80%。根據2021年國家醫學圖書館發表的一篇文章 ，約 23%的急性胰臟炎患者可能在出院三年內患有糖尿病。此外，2020年《胃腸病學雜誌》上發表的一篇文章 指出，急性胰臟炎後，約有3%、7%、9%和11%的患者在出院6、12、18 和24 個月時分別發展為糖尿病。根據MDPI發表的一篇文章指出，到2023年，約40%的急性胰臟炎患者受到糖尿病前期和糖尿病的影響，與2型糖尿病患者相比，其死亡和再入院的風險更高。此外，大約 60.2%的成人患者在急性胰臟炎後發展為糖尿病，9%的兒童在急性復發性胰臟炎或慢性胰臟炎後發展為糖尿病，而且這種風險隨著年齡的成長而增加。研究人員在一項比較重症和輕度急性胰臟炎的統合分析中發現，重症急性胰臟炎後糖尿病的發生率(約 39%)高於輕度急性胰臟炎(14%)。

中國的一項研究表明，高三酸甘油脂血症(HTG)已超過酒精，成為急性胰臟炎的第二大原因。約 29%的患者反覆發作，導致復發性急性胰臟炎(RAP)，其中 44.6%的患者有 HTG 作為病因。2023年 6月發表在 Biomed Central 上的一篇文章 中，HTG 被認為是急性胰臟炎嚴重程度和復發的重要獨立危險因子。因此，急性胰臟炎患者或復健患者中糖尿病發病率的增加促進了急性胰臟炎市場的成長。

急性胰臟炎市場分為產品和最終用戶。根據產品，急性胰臟炎市場分為藥物、診斷等。2022年，診斷領域佔最大市場佔有率。此外，其他細分市場預計在預測期內(2022-2030年)將創下最快的年複合成長率。診斷領域的急性胰臟炎市場進一步細分為血液檢查、CT掃描、糞便檢查、超音波、MRI和尿液檢查。依病因，急性胰臟炎市場分為膽結石、酗酒、遺傳性疾病、感染等。2022年，膽結石細分市場佔據最大市場佔有率。預計同一細分市場在預測期內(2022-2030年)將創下最高年複合成長率。根據最終用戶，急性胰臟炎市場分為醫院、診斷實驗室、門診手術中心等。2022年，醫院領域佔據最大的市場佔有率。診斷實驗室領域的急性胰臟炎市場預計在預測期內(2022-2030年)將以 6.4%的年複合成長率成長。

根據地理位置，市場分為北美、歐洲、亞太地區、中東和非洲以及南美洲和中美洲。北美地區在急性胰臟炎市場中佔有最大的市場佔有率。由於膽結石病例數增加和過量飲酒導致疾病負擔不斷增加，北美急性胰臟炎市場預計將成長。此外，醫療保健設施的技術進步也有利於北美的急性胰臟炎市場。由於大規模飲酒和膽結石病例激增，美國報告的急性胰臟炎病例數量不斷增加。預計亞太地區在2022年至2030年期間將達到最高成長率。亞太地區的市場成長歸因於胰臟炎病例增加、研究人員開發胰臟炎治療方法以及政府努力提高民眾認知等因素。此外，與酒精相關的胰臟炎病例也推動了該地區市場的成長。

經濟合作暨發展組織(OECD)、疾病管制與預防中心(CDC)、歐盟和美國國立衛生研究院(NIH)是在準備報告時提到的一些關鍵的一手和二手資料來源。急性胰臟炎市場。

目錄

第1章 簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第2章 執行摘要

  • 重要見解
  • 急性胰臟炎市場(按地理位置)

第3章 研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第4章 急性胰臟炎市場格局

  • 概述
  • PEST分析
    • 全球PEST分析

第5章 急性胰臟炎市場 - 主要產業動態

  • 主要市場促進因素
    • 急性胰臟炎導致胰臟癌病例增加
    • 急性胰臟炎後糖尿病發生率上升
  • 主要市場限制
    • 胰臟炎和胰臟癌治療的副作用
  • 主要市場機會
    • 急性胰臟炎的研發活動和宣傳計畫數量激增
  • 未來的趨勢
    • 特異性急性胰臟炎治療的進展
  • 影響分析：

第6章 急性胰臟炎市場 - 全球市場分析

  • 急性胰臟炎市場收入，2022 -2030

第7章 全球急性胰臟炎市場 -2030年收入和預測 - 依產品分類

  • 概述
  • 2022年及2030年急性胰臟炎市場收入佔有率(依產品分類)(%)
  • 藥物
  • 診斷
  • 其他

第8章 全球急性胰臟炎市場 -2030年收入和預測 - 按原因

  • 概述
  • 2022年及2030年急性胰臟炎市場收入佔有率(按原因分類)
  • 膽結石
  • 酗酒
  • 遺傳性疾病
  • 感染
  • 其他

第9章 全球急性胰臟炎市場 - 收入和2030年預測 - 依最終用戶

  • 概述
  • 2022年和2030年依最終用戶分類的急性胰臟炎市場收入佔有率(%)
  • 醫院
  • 診斷實驗室
  • 門診手術中心
  • 其他

第10章 急性胰臟炎市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 北歐地區
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第11章 急性胰臟炎市場-產業格局

  • 概述
  • 急性胰臟炎市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第12章 公司簡介

  • Abbott Laboratories
  • GE HealthCare Technologies Inc
  • Samsung Healthcare
  • Koninklijke Philips NV
  • Baxter International Inc
  • Dynavax Technologies Corp
  • Actim Oy
  • Medtronic Plc
  • Boston Scientific Corp
  • Fresenius Kabi AG

第13章 附錄

  • 關於我們
  • 專業術語
Product Code: TIPRE00017674

The acute pancreatitis market size is expected to reach US$ 8,827.37 million by 2030 from US$ 5,649.77 million in 2022; it is estimated to record a CAGR of 5.7% from 2022 to 2030.

The pancreas produces insulin, a hormone that regulates blood sugar levels. Pancreatitis can harm insulin-producing cells of pancreas, which causes diabetes in patients suffering from acute pancreatitis. People suffering from acute pancreatitis are at a twofold greater risk of diabetes as compared to the general population. The World Health Organization (WHO) American Diabetes Association has classified the development of diabetes after acute pancreatitis as exocrine pancreatic diabetes (pancreatogenic diabetes). Pancreatogenic diabetes is increasingly being linked to exocrine disorders of the pancreas. Diabetes sequelae are observed across the spectrum of severity in acute pancreatitis and can accompany other clinical complications.

As per the European Review for Medical and Pharmacological Sciences, published in 2022, the prevalence of pancreatogenic diabetes is 5-10% in the Western diabetic population, and chronic pancreatitis is responsible for 20% of cases while acute pancreatitis causes 80% of cases. According to an article published in the National Library of Medicine in 2021, ~23% of acute pancreatitis patients are likely to develop diabetes within three years of discharge. Further, an article published in the Journal of Gastroenterology in 2020 states that following acute pancreatitis, ~3%, 7%, 9%, and 11% of patients develop diabetes at 6, 12, 18, and 24 months of discharge, respectively. According to an article published in the MDPI, in 2023, ~40% of patients with acute pancreatitis are affected by prediabetes and diabetes, and are at a higher risk of death and readmission to hospitals than patients with type 2 diabetes. Further, ~ 60.2% of adult patients developed diabetes after acute pancreatitis, and 9% of children after acute recurrent pancreatitis or with chronic pancreatitis, and this risk increases as they age into adulthood. Researchers have noted higher diabetes incidence (~39%) after severe acute pancreatitis than mild acute pancreatitis (14%) in a meta-analysis comparing severe and mild acute pancreatitis.

A Chinese research study suggests that hypertriglyceridemia (HTG) has outpaced alcohol to become the second leading cause of acute pancreatitis. Approximately 29% of patients experience repeated episodes that result in recurrent acute pancreatitis (RAP) and 44.6% of these patients had HTG as an etiological condition. In an article published in Biomed Central in June 2023, HTG has been stated as a significant independent risk factor for the severity and recurrence of acute pancreatitis. Thus, the increasing incidence of diabetes in patients suffering or recovering from acute pancreatitis contributes to the growth of the acute pancreatitis market.

The acute pancreatitis market is segments into product and end user. Based on offerings, the Acute Pancreatitis Market is segmented into medication, diagnosis, and others. In 2022, the diagnosis segment held the largest share of the market. Moreover, the others segment is expected to record the fastest CAGR during the forecast period (2022-2030). The acute pancreatitis market for the diagnosis segment is further segmented into blood tests, CT scans, stool tests, ultrasound, MRI, and urine tests. Based on causes, the acute pancreatitis market is classified into gallstones, alcoholism, genetic disorders, infection, and others. In 2022, the gallstones segment held the largest share of the market. The same segment is expected to record the highest CAGR rate during the forecast period (2022-2030). Based on end user, the acute pancreatitis market is classified into hospitals, diagnostic laboratories, ambulatory surgical centers, and others. In 2022, the hospitals segment held the largest share of the market. The acute pancreatitis market for the diagnostic laboratories segment is estimated to grow at a CAGR of 6.4% during the forecast period (2022-2030).

Based on geopgraphy, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The North America fregion held the largest market share of the acute pancreatitis market. The acute pancreatitis market in North America is expected to grow due to the increasing burden of the disease with an increase in the number of gallstone cases and excessive consumption of alcohol. Also, technological advancements in healthcare facilities are benefitting the acute pancreatitis market in North America. The US reports an increasingly large number of acute pancreatitis cases due to a wide-scale practice of alcohol consumption and an upsurge in the cases of gallstones. APAC is expected to register the highest growth rate during 2022-2030. The market growth in APAC is attributed to factors including rising cases of pancreatitis, researchers to develop a treatment for pancreatitis, and government efforts to raise awareness among the population. In addition, alcohol-related pancreatitis cases also fuels the growth of the market in the region.

The Organisation for Economic Co-operation and Development (OECD), Centers for Disease Control and Prevention (CDC), European Union, and National Institutes of Health (NIH) are a few key primary and secondary sources referred to while preparing the report on the acute pancreatitis market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the acute pancreatitis market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global acute pancreatitis market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the acute pancreatitis market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Acute Pancreatitis Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Acute Pancreatitis Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Acute Pancreatitis Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
    • 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
  • 5.2 Key Market Restraints
    • 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
  • 5.3 Key Market Opportunities
    • 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
  • 5.4 Future Trends
    • 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
  • 5.5 Impact Analysis:

6. Acute Pancreatitis Market - Global Market Analysis

  • 6.1 Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

  • 7.1 Overview
  • 7.2 Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
  • 7.3 Medications
    • 7.3.1 Overview
    • 7.3.2 Medications: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Global Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
  • 7.4 Diagnosis
    • 7.4.1 Overview
    • 7.4.2 Diagnosis: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 Global Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

  • 8.1 Overview
  • 8.2 Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
  • 8.3 Gallstones
    • 8.3.1 Overview
    • 8.3.2 Gallstones: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Alcoholism
    • 8.4.1 Overview
    • 8.4.2 Alcoholism: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genetic Disorders
    • 8.5.1 Overview
    • 8.5.2 Genetic Disorders: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Infections
    • 8.6.1 Overview
    • 8.6.2 Infections: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Ambulatory Surgical Centers
    • 9.5.1 Overview
    • 9.5.2 Ambulatory Surgical Centers: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. Acute Pancreatitis Market - Geographical Analysis

  • 10.1 North America Acute Pancreatitis Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.3 North America: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
      • 10.1.3.1 North America: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
      • 10.1.3.2 North America: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    • 10.1.4 North America: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    • 10.1.5 North America: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.5.1 North America Acute Pancreatitis Market, by Country
      • 10.1.5.2 US
        • 10.1.5.2.1 Overview
        • 10.1.5.2.2 US Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.5.2.3 US: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.5.2.3.1 US: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.5.2.3.2 US: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.5.2.4 US: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.5.2.5 US: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.5.3 Canada
        • 10.1.5.3.1 Overview
        • 10.1.5.3.2 Canada Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.5.3.3 Canada: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.5.3.3.1 Canada: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.5.3.3.2 Canada: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.5.3.4 Canada: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.5.3.5 Canada: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.5.4 Mexico
        • 10.1.5.4.1 Overview
        • 10.1.5.4.2 Mexico Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.5.4.3 Mexico: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.5.4.3.1 Mexico: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.5.4.3.2 Mexico: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.5.4.4 Mexico: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.5.4.5 Mexico: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  • 10.2 Europe Acute Pancreatitis Market, Revenue and Forecast to 2030
    • 10.2.1 Overview
    • 10.2.2 Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.2.3 Europe: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
      • 10.2.3.1 Europe: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
      • 10.2.3.2 Europe: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    • 10.2.4 Europe: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    • 10.2.5 Europe: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.2.5.1 Europe Acute Pancreatitis Market, by Country
      • 10.2.5.2 UK
        • 10.2.5.2.1 Overview
        • 10.2.5.2.2 UK Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.5.2.3 UK: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.2.3.1 UK: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.2.3.2 UK: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.2.4 UK: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.2.5.2.5 UK: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.2.5.3 Germany
        • 10.2.5.3.1 Overview
        • 10.2.5.3.2 Germany Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.5.3.3 Germany: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.3.3.1 Germany: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.3.3.2 Germany: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.3.4 Germany: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.2.5.3.5 Germany: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.2.5.4 France
        • 10.2.5.4.1 Overview
        • 10.2.5.4.2 France Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.5.4.3 France: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.4.3.1 France: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.4.3.2 France: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.4.4 France: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.2.5.4.5 France: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.2.5.5 Italy
        • 10.2.5.5.1 Overview
        • 10.2.5.5.2 Italy Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.5.5.3 Italy: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.5.3.1 Italy: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.5.3.2 Italy: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.5.4 Italy: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.2.5.5.5 Italy: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.2.5.6 Spain
        • 10.2.5.6.1 Overview
        • 10.2.5.6.2 Spain Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.5.6.3 Spain: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.6.3.1 Spain: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.6.3.2 Spain: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.6.4 Spain: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.2.5.6.5 Spain: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.2.5.7 Nordic Region
        • 10.2.5.7.1 Overview
        • 10.2.5.7.2 Nordic Region Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.5.7.3 Nordic Region: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.7.3.1 Nordic Region: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.7.3.2 Nordic Region: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.7.4 Nordic Region: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.2.5.7.5 Nordic Region: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.2.5.8 Netherlands
        • 10.2.5.8.1 Overview
        • 10.2.5.8.2 Netherlands Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.5.8.3 Netherlands: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.8.3.1 Netherlands: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.8.3.2 Netherlands: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.8.4 Netherlands: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.2.5.8.5 Netherlands: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.2.5.9 Rest of Europe
        • 10.2.5.9.1 Overview
        • 10.2.5.9.2 Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.5.9.3 Rest of Europe: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.9.3.1 Rest of Europe: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.9.3.2 Rest of Europe: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.2.5.9.4 Rest of Europe: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.2.5.9.5 Rest of Europe: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  • 10.3 Asia Pacific Acute Pancreatitis Market, Revenue and Forecast to 2030
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.3.3 Asia Pacific: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
      • 10.3.3.1 Asia Pacific: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
      • 10.3.3.2 Asia Pacific: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    • 10.3.4 Asia Pacific: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    • 10.3.5 Asia Pacific: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.3.5.1 Asia Pacific Acute Pancreatitis Market, by Country
      • 10.3.5.2 China
        • 10.3.5.2.1 Overview
        • 10.3.5.2.2 China Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.5.2.3 China: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.2.3.1 China: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.2.3.2 China: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.2.4 China: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.3.5.2.5 China: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.3.5.3 Japan
        • 10.3.5.3.1 Overview
        • 10.3.5.3.2 Japan Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.5.3.3 Japan: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.3.3.1 Japan: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.3.3.2 Japan: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.3.4 Japan: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.3.5.3.5 Japan: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.3.5.4 India
        • 10.3.5.4.1 Overview
        • 10.3.5.4.2 India Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.5.4.3 India: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.4.3.1 India: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.4.3.2 India: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.4.4 India: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.3.5.4.5 India: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.3.5.5 Australia
        • 10.3.5.5.1 Overview
        • 10.3.5.5.2 Australia Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.5.5.3 Australia: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.5.3.1 Australia: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.5.3.2 Australia: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.5.4 Australia: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.3.5.5.5 Australia: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.3.5.6 South Korea
        • 10.3.5.6.1 Overview
        • 10.3.5.6.2 South Korea Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.5.6.3 South Korea: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.6.3.1 South Korea: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.6.3.2 South Korea: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.6.4 South Korea: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.3.5.6.5 South Korea: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.3.5.7 Rest of Asia Pacific
        • 10.3.5.7.1 Overview
        • 10.3.5.7.2 Rest of Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.5.7.3 Rest of Asia Pacific: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.7.3.1 Rest of Asia Pacific: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.7.3.2 Rest of Asia Pacific: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.3.5.7.4 Rest of Asia Pacific: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.3.5.7.5 Rest of Asia Pacific: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  • 10.4 Middle East & Africa Acute Pancreatitis Market, Revenue and Forecast to 2030
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.4.3 Middle East & Africa: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
      • 10.4.3.1 Middle East & Africa: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
      • 10.4.3.2 Middle East & Africa: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    • 10.4.4 Middle East & Africa: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    • 10.4.5 Middle East & Africa: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.4.5.1 Middle East & Africa Acute Pancreatitis Market, by Country
      • 10.4.5.2 Saudi Arabia
        • 10.4.5.2.1 Overview
        • 10.4.5.2.2 Saudi Arabia Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.5.2.3 Saudi Arabia: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.2.3.1 Saudi Arabia: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.2.3.2 Saudi Arabia: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.2.4 Saudi Arabia: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.4.5.2.5 Saudi Arabia: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.4.5.3 UAE
        • 10.4.5.3.1 Overview
        • 10.4.5.3.2 UAE Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.5.3.3 UAE: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.3.3.1 UAE: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.3.3.2 UAE: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.3.4 UAE: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.4.5.3.5 UAE: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.4.5.4 South Africa
        • 10.4.5.4.1 Overview
        • 10.4.5.4.2 South Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.5.4.3 South Africa: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.4.3.1 South Africa: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.4.3.2 South Africa: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.4.4 South Africa: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.4.5.4.5 South Africa: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.4.5.5 Rest of Middle East & Africa
        • 10.4.5.5.1 Overview
        • 10.4.5.5.2 Rest of Middle East & Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.5.5.3 Rest of Middle East & Africa: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.5.3.1 Rest of Middle East & Africa: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.5.3.2 Rest of Middle East & Africa: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.4.5.5.4 Rest of Middle East & Africa: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.4.5.5.5 Rest of Middle East & Africa: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
  • 10.5 South & Central America Acute Pancreatitis Market, Revenue and Forecast to 2030
    • 10.5.1 Overview
    • 10.5.2 South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.5.3 South & Central America: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
      • 10.5.3.1 South & Central America: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
      • 10.5.3.2 South & Central America: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
    • 10.5.4 South & Central America: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
    • 10.5.5 South & Central America: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.5.5.1 South & Central America Acute Pancreatitis Market, by Country
      • 10.5.5.2 Brazil
        • 10.5.5.2.1 Overview
        • 10.5.5.2.2 Brazil Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.5.2.3 Brazil: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.5.5.2.3.1 Brazil: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.5.5.2.3.2 Brazil: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.5.5.2.4 Brazil: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.5.5.2.5 Brazil: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.5.5.3 Argentina
        • 10.5.5.3.1 Overview
        • 10.5.5.3.2 Argentina Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.5.3.3 Argentina: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.5.5.3.3.1 Argentina: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.5.5.3.3.2 Argentina: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.5.5.3.4 Argentina: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.5.5.3.5 Argentina: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.5.5.4 Rest of South & Central America
        • 10.5.5.4.1 Overview
        • 10.5.5.4.2 Rest of South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.5.4.3 Rest of South & Central America: Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.5.5.4.3.1 Rest of South & Central America: Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.5.5.4.3.2 Rest of South & Central America: Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.5.5.4.4 Rest of South & Central America: Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.5.5.4.5 Rest of South & Central America: Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)

11. Acute Pancreatitis Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Acute Pancreatitis Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 GE HealthCare Technologies Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Samsung Healthcare
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Koninklijke Philips NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Baxter International Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Dynavax Technologies Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Actim Oy
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Boston Scientific Corp
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Fresenius Kabi AG
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Acute Pancreatitis Market Segmentation
  • Table 2. Global Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Global Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. North America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Mexico Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. UK Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. UK Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. UK Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. UK Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. UK Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Germany Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Germany Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Germany Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Germany Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Germany Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. France Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. France Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. France Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. France Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. France Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Italy Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Italy Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Italy Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Italy Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Italy Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Spain Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Spain Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. Spain Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Spain Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Spain Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Nordic Region Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Nordic Region Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Nordic Region Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Nordic Region Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Nordic Region Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Netherlands Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Netherlands Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Netherlands Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Netherlands Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Netherlands Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Rest of Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Rest of Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Rest of Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Rest of Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Rest of Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. China Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. China Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. China Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. China Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. China Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. Japan Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. Japan Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Japan Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Japan Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Japan Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. India Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. India Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. India Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. India Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. India Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. Australia Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Australia Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Australia Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Australia Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Australia Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. South Korea Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. South Korea Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. South Korea Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. South Korea Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. South Korea Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Rest of Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Rest of Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Rest of Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. Rest of Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. Rest of Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. Middle East & Africa Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. Middle East & Africa Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Middle East & Africa Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Middle East & Africa Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Middle East & Africa Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Saudi Arabia Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Saudi Arabia Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. Saudi Arabia Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. Saudi Arabia Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 113. Saudi Arabia Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 114. UAE Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 115. UAE Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 116. UAE Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 117. UAE Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 118. UAE Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 119. South Africa Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 120. South Africa Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 121. South Africa Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 122. South Africa Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 123. South Africa Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 124. Rest of Middle East & Africa Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 125. Rest of Middle East & Africa Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 126. Rest of Middle East & Africa Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 127. Rest of Middle East & Africa Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 128. Rest of Middle East & Africa Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 129. South & Central America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 130. South & Central America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 131. South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 132. South & Central America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 133. South & Central America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 134. Brazil Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 135. Brazil Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Brazil Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Brazil Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Brazil Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 139. Argentina Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 140. Argentina Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 141. Argentina Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 142. Argentina Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 143. Argentina Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 144. Rest of South & Central America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 145. Rest of South & Central America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 146. Rest of South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 147. Rest of South & Central America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 148. Rest of South & Central America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 149. Recent Inorganic Growth Strategies in the Acute Pancreatitis Market
  • Table 150. Recent Organic Growth Strategies in the Acute Pancreatitis Market
  • Table 151. Glossary of Terms, Acute Pancreatitis Market

List Of Figures

  • Figure 1. Acute Pancreatitis Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Acute Pancreatitis Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Acute Pancreatitis Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 7. Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
  • Figure 8. Medications: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Diagnosis: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
  • Figure 12. Gallstones: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Alcoholism: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Genetic Disorders: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Infections: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 18. Hospitals: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Diagnostic Laboratories: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Ambulatory Surgical Centers: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America: Acute Pancreatitis Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. North America Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
  • Figure 25. US Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Canada Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Mexico Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Europe Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 29. Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Europe Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
  • Figure 31. UK Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Germany Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. France Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Italy Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Spain Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Nordic Region Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Netherlands Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Asia Pacific Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 40. Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Asia Pacific Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
  • Figure 42. China Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Japan Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. India Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Australia Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. South Korea Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Middle East & Africa Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 49. Middle East & Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. Middle East & Africa Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
  • Figure 51. Saudi Arabia Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. UAE Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. South Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Rest of Middle East & Africa Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. South & Central America Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 56. South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. South & Central America Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
  • Figure 58. Brazil Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Argentina Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Rest of South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Growth Strategies in the Acute Pancreatitis Market